Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Bruzzi

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trialMatteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Tumori|June 15, 2007
Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesotheliomaMarcello Tiseo, Olga Martelli, Andrea Mancuso, et al.
Clinical and Vaccine Immunology : CVI|October 14, 2011
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infectionsValerio Del Bono, Emanuele Delfino, Elisa Furfaro, et al.
Breast Cancer Research and Treatment|September 16, 2008
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancerAlessandra Gennari, Michele De Tursi, Consiglia Carella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 29, 2009
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habitsMassimo Bellini, Antonio Bove, Maria Pia Sormani, et al.
Annals of Surgical Oncology|March 16, 2016
Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical TrialGiuseppe Canavese, Paolo Bruzzi, Alessandra Catturich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trialsAlessandra Gennari, Martin Stockler, Matteo Puntoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studiesAlfredo Berruti, Vito Amoroso, Fabio Gallo, et al.
Journal of Gastroenterology|October 16, 2012
Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trialLuigina Bonelli, Matteo Puntoni, Beatrice Gatteschi, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trialMatteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Tumori|June 15, 2007
Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesotheliomaMarcello Tiseo, Olga Martelli, Andrea Mancuso, et al.
Clinical and Vaccine Immunology : CVI|October 14, 2011
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infectionsValerio Del Bono, Emanuele Delfino, Elisa Furfaro, et al.
Breast Cancer Research and Treatment|September 16, 2008
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancerAlessandra Gennari, Michele De Tursi, Consiglia Carella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 29, 2009
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habitsMassimo Bellini, Antonio Bove, Maria Pia Sormani, et al.
Annals of Surgical Oncology|March 16, 2016
Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical TrialGiuseppe Canavese, Paolo Bruzzi, Alessandra Catturich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trialsAlessandra Gennari, Martin Stockler, Matteo Puntoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studiesAlfredo Berruti, Vito Amoroso, Fabio Gallo, et al.
Journal of Gastroenterology|October 16, 2012
Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trialLuigina Bonelli, Matteo Puntoni, Beatrice Gatteschi, et al.
Pageof 16